NASDAQ · VVOS
Healthcare · Medical - Devices
$0.31
Up+$0.02 (+6.75%)
Updated Aug 14, 2026, 6:23 AM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
VVOS closed at $0.31 after 21 trading sessions, down 26.04% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $0.2867 | $0.315 | $0.2797 | $0.3053 | 703.75K |
| Aug 12, 2026 | $0.3086 | $0.3086 | $0.271 | $0.286 | 1.17M |
| Aug 11, 2026 | $0.332 | $0.36 | $0.29 | $0.3147 | 5.98M |
| Aug 10, 2026 | $0.3263 | $0.338 | $0.315 | $0.3177 | 711.43K |
| Aug 7, 2026 | $0.3175 | $0.3544 | $0.31 | $0.324 | 1.33M |
| Aug 6, 2026 | $0.3368 | $0.3449 | $0.32 | $0.322 | 1.31M |
| Aug 5, 2026 | $0.31 | $0.3478 | $0.3019 | $0.3406 | 7.63M |
| Aug 4, 2026 | $0.425 | $0.54 | $0.4201 | $0.4622 | 35.48M |
| Aug 3, 2026 | $0.42 | $0.4328 | $0.4121 | $0.4206 | 110.98K |
| Jul 31, 2026 | $0.406 | $0.4198 | $0.3935 | $0.41 | 186.06K |
| Jul 30, 2026 | $0.4199 | $0.426 | $0.4042 | $0.4059 | 40.43K |
| Jul 29, 2026 | $0.44 | $0.4401 | $0.4101 | $0.4139 | 228.54K |
| Jul 28, 2026 | $0.405 | $0.4296 | $0.3803 | $0.42 | 232.41K |
| Jul 27, 2026 | $0.417 | $0.417 | $0.3864 | $0.403 | 131.13K |
| Jul 24, 2026 | $0.383 | $0.41 | $0.3637 | $0.3931 | 152.92K |
| Jul 23, 2026 | $0.3984 | $0.41 | $0.39 | $0.3906 | 285.69K |
| Jul 22, 2026 | $0.41 | $0.4164 | $0.4037 | $0.404 | 125.22K |
| Jul 21, 2026 | $0.418 | $0.4199 | $0.4009 | $0.4148 | 111K |
| Jul 20, 2026 | $0.43 | $0.44 | $0.405 | $0.4112 | 70.96K |
| Jul 17, 2026 | $0.4004 | $0.4209 | $0.3861 | $0.4195 | 131.52K |
| Jul 16, 2026 | $0.43 | $0.431 | $0.4031 | $0.4128 | 181.55K |
The latest Smart Investors Daily articles mentioning VVOS.
VVOS research
Company profile and research snapshot.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 4, 2026 | Ascendiant Capital | Buy | — |
| Apr 22, 2026 | Ascendiant Capital | Buy | — |
| Apr 17, 2026 | HC Wainwright & Co. | Buy | — |
| Dec 3, 2025 | Ascendiant Capital | Buy | — |
| Nov 17, 2025 | HC Wainwright & Co. | Buy | — |
No generated briefing is available yet.
Yahoo · Feb 14, 2026
The show broadcasts as sponsored programming with national TV commercials from Synergy CHC (NASDAQ:SNYR), NeOnc Technologies (NASDAQ:NTHI), PetVivo (OTCQX:PETV), and YY Group Holdings (NASDAQ:YYGH). NEW YORK CITY, NEW YORK / ACCESS Newswire / February ...
Benzinga · Feb 5, 2026
Vivos adds more cutting-edge products to its roster serving the breathing and sleep wellness marketLITTLETON, Colo., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ:VVOS), a
Yahoo · Nov 27, 2025
Vivos Therapeutics Inc (VVOS) reports a 76% revenue increase in Q3 2025, driven by strategic acquisitions and expanded service offerings.
Yahoo · Nov 19, 2025
Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations Management to host conference call today at 5:00 pm ET to review results and provide operational updates LITTLETON, Colo., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing in the delivery of highly effective d
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning VVOS.
